Dr. Jeffrey Shuren, head of the Center for Devices & Radiological Health, tells a Woburn, Mass., town hall meeting that a report on the Food & Drug Administration's internal review of the 510(k) process is due within the next several weeks.
Dr. Jeffrey Shuren, head of the Food & Drug Administration's medical device oversight arm, told a Massachusetts audience that results from the agency's internal, soup-to-nuts review of its 510(k) clearance program are due out in a few weeks.
At the second in a series of "town hall" meetings in Woburn, Mass., the Center for Devices & Radiological Health's leader said the federal watchdog would seek public comment on the report before making any changes to the program.
Shuren told MassDevice that the agency still hasn't decided exactly what changes are in store for the 510(k) process.
Boston Scientific's Lotus TAVI system minimizes leakage in an early trial, St. Jude Medical gains on...
Electromed founder, chairman & CEO Robert Hansen announces his retirement after 20 years leading...
St. Jude Medical's shares get a 2% lift from an upgrade by a Goldman Sachs analyst.
Just weeks before a $2.3 billion acquisition by Asahi Kasei closed, the Securities & Exchange...
Boston Scientific's Synergy bioabsorbable drug-eluting stent proves just as good as its leading and...